Veyonda®
Various cancers (investigational)
Phase 1Active
Key Facts
About Noxopharm
Australian biotech leveraging Sofra™ and Chroma™ platforms to develop oncology and mRNA‑based immunotherapy candidates.
View full company profileVarious cancers (investigational)
Australian biotech leveraging Sofra™ and Chroma™ platforms to develop oncology and mRNA‑based immunotherapy candidates.
View full company profile